United Therapeutics
Trade United Therapeutics 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About UTHR
United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin.
UTHR Key Statistics
Stock Snapshot
With a market cap of 23.13B, United Therapeutics(UTHR) trades at $544.92. The stock has a price-to-earnings ratio of 20.03.
On 2026-06-30, United Therapeutics(UTHR) stock moved within a range of $539.14 to $549.38. With shares now at $544.92, the stock is trading +1.1% above its intraday low and -0.8% below the session's peak.
Trading activity shows a volume of 420.26K, compared to an average daily volume of 713.35K.
Over the past 52 weeks, United Therapeutics(UTHR) stock has traded between a high of $609.35 and a low of $272.12.
Over the past 52 weeks, United Therapeutics(UTHR) stock has traded between a high of $609.35 and a low of $272.12.
UTHR News
Unlock powerful investing tools and data-driven insights with TipRanks Premium for more confident investment decisions. Discover top stock picks and new invest...
...
United Therapeutics (UTHR) announced that the U.S. FDA has granted premarket approval of the LungFX device for use in centralized ex vivo lung perfusion, a proc...
Analyst ratings
81%
of 16 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.